# Evofem Biosciences

Evofem Biosciences is an other based in San Diego, United States.

## Overview

- **Organization type:** other
- **Headquarters:** San Diego, United States
- **Region:** North America
- **Address:** San Diego, CA, United States
- **Founded:** 1995
- **Assets under management:** Undisclosed
- **Website:** evofem.com
- **LinkedIn:** https://www.linkedin.com/company/evofem

## Regulatory record

- **Reports private funds:** No

## About

Evofem Biosciences is a biotechnology company based in San Diego, United States, founded in 2009. It develops reproductive and contraceptive care products for women globally. The company has secured $112.8 million in total funding.

## Sectors

- Biotech
- Pharmaceuticals
- Women's Health

## Questions

### Who runs investment decisions at Evofem?

Evofem Biosciences is a publicly traded company. Investment decisions, including capital allocation for R&D and commercial activities, are made by the board of directors and management team, led by CEO Saundra Pelletier. The company does not function as a family office; its operations are governed by SEC disclosure rules.

### How does Evofem source proprietary deal flow?

Evofem sources deal flow through licensing agreements, partnerships, and co-promotion deals within the biotech and pharmaceutical sectors. For example, it has partnered with AMAG Pharmaceuticals for co-promotion of Phexxi (per SEC filing, 2020). The firm's pipeline includes in-licensed candidates, though it does not disclose a proprietary sourcing method.

### Does Evofem participate in fund commitments or only direct deals?

Evofem does not participate in fund commitments as an LP. As a public company, its capital is raised through equity offerings, debt, and revenue from product sales. It engages in direct licensing and partnership deals for its pipeline assets.

### Which sectors does Evofem explicitly avoid?

Evofem focuses exclusively on women's sexual and reproductive health. It avoids oncology, cardiovascular, neurology, and other therapeutic areas. The company's pipeline is centered on non-hormonal contraception, infection prevention, and reproductive health, as stated in its public filings.

## Related profiles

- [Antipodean Advisors](https://altss.com/profile/antipodean-advisors)
- [Pathway Vet Alliance](https://altss.com/profile/pathway-vet-alliance-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/evofem-biosciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology